Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Nov;16(11):1772-1782.
doi: 10.1016/j.soard.2020.06.032. Epub 2020 Jun 27.

Fecal metagenomics and metabolomics reveal gut microbial changes after bariatric surgery

Affiliations
Observational Study

Fecal metagenomics and metabolomics reveal gut microbial changes after bariatric surgery

Danxia Yu et al. Surg Obes Relat Dis. 2020 Nov.

Abstract

Background: Evidence from longitudinal patient studies regarding gut microbial changes after bariatric surgery is limited.

Objective: To examine intraindividual changes in fecal microbiome and metabolites among patients undergoing Roux-en-Y gastric bypass or vertical sleeve gastrectomy.

Setting: Observational study.

Methods: Twenty patients were enrolled and provided stool samples before and 1 week, 1 month, and/or 3 months after surgery. Shallow shotgun metagenomics and untargeted fecal metabolomics were performed. Zero-inflated generalized additive models and linear mixed models were applied to identify fecal microbiome and metabolites changes, with adjustment for potential confounders and correction for multiple testing.

Results: We enrolled 16 women and 4 men, including 16 white and 4 black participants (median age = 45 years; presurgery body mass index = 47.7 kg/m2). Ten patients had Roux-en-Y gastric bypass, 10 had vertical sleeve gastrectomy, and 14 patients provided postsurgery stool samples. Of 47 samples, median sequencing depth was 6.3 million reads and 1073 metabolites were identified. Microbiome alpha-diversity increased after surgery, especially at 3 months. Significant genus-level changes included increases in Odoribacter, Streptococcus, Anaerotruncus, Alistipes, Klebsiella, and Bifidobacterium, while decreases in Bacteroides, Coprocosccus, Dorea, and Faecalibacterium. Large increases in Streptococcus, Akkermansia, and Prevotella were observed at 3 months. Beta-diversity and fecal metabolites were also changed, including reduced caffeine metabolites, indoles, and butyrate.

Conclusions: Despite small sample size and missing repeated samples in some participants, our pilot study showed significant postsurgery changes in fecal microbiome and metabolites among bariatric surgery patients. Future large-scale, longitudinal studies are warranted to investigate gut microbial changes and their associations with metabolic outcomes after bariatric surgery.

Keywords: Bariatric surgery; Fecal metabolomics; Gut microbiota; Longitudinal patient cohort; Metagenomics.

PubMed Disclaimer

Conflict of interest statement

Disclosures

The authors have no commercial associations that might be a conflict of interest in relation to this article.

Figures

Fig. 1.
Fig. 1.
Fecal microbiome alpha- and beta-diversity indices before and after bariatric surgery. (a) Shannon index (0 = presurgery; 7 = 1 wk; 30 = 1 mo; 90 = 3 mo after surgery; linear mixed model, P = .004 for pre versus 1 wk; .54 for pre versus 1 mo; .04 for pre versus 3 mo). (b) Bray-Curtis distance (principle co-ordinates analysis plot; red = presurgery; blue = postsurgery; permutation multivariate analysis of variance P = .015)

Comment in

References

    1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief 2020;(360):1–8. - PubMed
    1. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013;309(21):2240–9. - PMC - PubMed
    1. Isaman DJ, Rothberg AE, Herman WH. Reconciliation of type 2 diabetes remission rates in studies of Roux-en-Y gastric bypass. Diabetes Care 2016;39(12):2247–53. - PMC - PubMed
    1. Carswell KA, Belgaumkar AP, Amiel SA, Patel AG. A systematic review and meta-analysis of the effect of gastric bypass surgery on plasma lipid levels. Obes Surg 2016;26(4):843–55. - PubMed
    1. Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension: the GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation 2018;137(11):1132–42. - PMC - PubMed

Publication types

LinkOut - more resources